lactic acid and xanthone

lactic acid has been researched along with xanthone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afonso, CM; Barbosa, CM; Pinto, MM; Teixeira, M1
Alonso, MJ; Barbosa, CM; Pinto, MM; Teixeira, M1
Barbosa, CM; Lima, RT; Paiva, AM; Pinto, M; Pinto, RA; Sousa, E; Teixeira, M; Vasconcelos, MH1

Other Studies

3 other study(ies) available for lactic acid and xanthone

ArticleYear
A validated HPLC method for the assay of xanthone and 3-methoxyxanthone in PLGA nanocapsules.
    Journal of chromatographic science, 2003, Volume: 41, Issue:7

    Topics: Capsules; Chromatography, High Pressure Liquid; Lactic Acid; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Xanthenes; Xanthones

2003
Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2005, Volume: 59, Issue:3

    Topics: Capsules; Drug Stability; Lactic Acid; Microspheres; Nanostructures; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Xanthones

2005
Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53-MDM2 interaction.
    International journal of pharmaceutics, 2013, Sep-15, Volume: 454, Issue:1

    Topics: Biological Transport; Cell Proliferation; Chemistry, Pharmaceutical; Coumarins; Dose-Response Relationship, Drug; Drug Carriers; Female; Fluorescent Dyes; Humans; Kinetics; Lactic Acid; MCF-7 Cells; Microscopy, Electron, Scanning; Molecular Targeted Therapy; Nanocapsules; Nanotechnology; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Proto-Oncogene Proteins c-mdm2; Solubility; Technology, Pharmaceutical; Triglycerides; Tumor Suppressor Protein p53; Xanthones

2013